日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Characterization of the aryl hydrocarbon receptor as a potential candidate to improve cancer T cell therapies.

对芳烃受体进行表征,以期改进癌症 T 细胞疗法

De Castro Valentine, Abdellaoui Oumaïma, Dehecq Barbara, Ndao Babacar, Mercier-Letondal Patricia, Dauvé Alexandra, Garnache-Ottou Francine, Adotévi Olivier, Loyon Romain, Godet Yann

Beneficial effect of resveratrol on T cell oxidative metabolism and anti-tumor function is conditioned by prior in vivo T cell history.

白藜芦醇对 T 细胞氧化代谢和抗肿瘤功能的有益作用取决于先前体内 T 细胞的历史

Mercier-Letondal Patricia, Marton Chrystel, Royer Bernard, Peixoto Paul, Dehecq Barbara, Adotévi Olivier, Galaine Jeanne, Godet Yann

Erratum to: New CD20 alternative splice variants: molecular identification and differential expression within hematological B cell malignancies

勘误:CD20 新剪接变体:血液 B 细胞恶性肿瘤中的分子鉴定和差异表达

Gamonet, Clémentine; Bole-Richard, Elodie; Delherme, Aurélia; Aubin, François; Toussirot, Eric; Garnache-Ottou, Francine; Godet, Yann; Ysebaert, Loïc; Tournilhac, Olivier; Dartigeas, Caroline; Larosa, Fabrice; Deconinck, Eric; Saas, Philippe; Borg, Christophe; Deschamps, Marina; Ferrand, Christophe

Interest of Tumor-Specific CD4 T Helper 1 Cells for Therapeutic Anticancer Vaccine

肿瘤特异性CD4 T辅助细胞1在治疗性抗癌疫苗中的价值

Galaine, Jeanne; Borg, Christophe; Godet, Yann; Adotévi, Olivier

Immunogenicity evaluation of a rationally designed polytope construct encoding HLA-A*0201 restricted epitopes derived from Leishmania major related proteins in HLA-A2/DR1 transgenic mice: steps toward polytope vaccine

在HLA-A2/DR1转基因小鼠中评估一种合理设计的、编码源自利什曼原虫相关蛋白的HLA-A*0201限制性表位的多表位构建体的免疫原性:多表位疫苗的研发进展

Seyed, Negar; Taheri, Tahereh; Vauchy, Charline; Dosset, Magalie; Godet, Yann; Eslamifar, Ali; Sharifi, Iraj; Adotevi, Olivier; Borg, Christophe; Rohrlich, Pierre Simon; Rafati, Sima

Universal tumor-reactive helper peptides from telomerase as new tools for anticancer vaccination

端粒酶来源的通用肿瘤反应辅助肽作为抗癌疫苗的新工具

Dosset, Magalie; Vauchy, Charline; Beziaud, Laurent; Adotevi, Olivier; Godet, Yann

Targeting antitumor CD4 helper T cells with universal tumor-reactive helper peptides derived from telomerase for cancer vaccine

利用源自端粒酶的通用肿瘤反应性辅助肽靶向抗肿瘤CD4辅助性T细胞,用于癌症疫苗

Adotévi, Olivier; Dosset, Magalie; Galaine, Jeanne; Beziaud, Laurent; Godet, Yann; Borg, Christophe

Is preexisting antitumor CD4 T cell response indispensable for the chemotherapy induced immune regression of cancer?

预先存在的抗肿瘤 CD4 T 细胞反应对于化疗诱导的癌症免疫消退是否必不可少?

Godet, Yann; Dosset, Magalie; Borg, Christophe; Adotevi, Olivier

Double positive CD4CD8 alphabeta T cells: a new tumor-reactive population in human melanomas

双阳性CD4CD8αβ T细胞:人类黑色素瘤中一种新的肿瘤反应性细胞群

Desfrançois, Juliette; Moreau-Aubry, Agnès; Vignard, Virginie; Godet, Yann; Khammari, Amir; Dréno, Brigitte; Jotereau, Francine; Gervois, Nadine

A new tyrosinase epitope recognized in the HLA-B*4002 context by CTL from melanoma patients.

黑色素瘤患者的 CTL 在 HLA-B*4002 背景下识别出一种新的酪氨酸酶表位

Godet Yann, Bonnin Annabelle, Guilloux Yannik, Vignard Virginie, Schadendorf Dirk, Dreno Brigitte, Jotereau Francine, Labarriere Nathalie